Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Framingham, MA
SEC filing record 1 source field available
Fiscal year end
30 September
Arch Therapeutics, Inc. has filed 558 SEC EDGAR filings since 05 Jan 2012

SEC filing history

Showing 1-25 of 558 matching filings.

Per page
25
Current page
1
15-12G File 000-54986

15-12G filing

Filing date
12 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
RW File 333-268008

RW

Filing date
23 May 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 000-54986

NT 10-K filing

Filing date
31 Dec 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87522

SC 13G/A filing

Filing date
13 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54986

10-Q filing

Filing date
19 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
NT 10-Q File 000-54986

NT 10-Q filing

Filing date
14 Aug 2024
Reporting date
30 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-268008

S-1/A filing

Filing date
20 Jun 2024
Reporting date
Not listed
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .